Overview

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.

Eligibility

Inclusion Criteria:

• Patient is going to be treated with Myval THV
• Age ≥ 18 years
• Ability to give informed consent

Exclusion Criteria:

• Pregnant and lactating women
• Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media.
• Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated.
• Any condition, which in the Investigator's opinion, would preclude safe participation of patient in the registry